Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bartosz Grzywacz

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Stem Cells and Development|May 14, 2019
Pioneering Adoptive Immunotherapy with Natural Killer CellsBartosz Grzywacz
Human Immunology|July 18, 2002
NK cells become Ki-67+ in MLC and expand depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLCBartosz Grzywacz, Dorota Dlubek, Andrzej Lange
Frontiers in Immunology|September 27, 2019
Human NK Cell Development: One Road or Many?Frank Cichocki, Bartosz Grzywacz, Jeffrey S Miller
Best Practice & Research. Clinical Haematology|September 16, 2008
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz, Jeffrey S Miller, Michael R Verneris
Cytometry. Part B, Clinical Cytometry|November 18, 2021
Patients without cutaneous T-cell lymphoma frequently harbor CD4 T-lymphocytes that lack CD26 and/or CD7Bartosz Grzywacz, Sophia Yohe, Paula Shivers, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 30, 2021
Hemophagocytic lymphohistiocytosis induced by Toxoplasma gondii infection diagnosed by a bone marrow biopsy and DNA next-generation sequencing in an allogeneic hematopoietic stem cell transplant recipientKaram M Obeid, Bartosz Grzywacz, Patricia Ferrieri, et al.
Blood|December 22, 2010
Natural killer-cell differentiation by myeloid progenitorsBartosz Grzywacz, Nandini Kataria, Niketa Kataria, et al.
American Journal of Clinical Pathology|July 16, 2019
CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-upScott R Gilles, Sophia L Yohe, Michael A Linden, et al.
Bone Marrow Transplantation|August 9, 2020
Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendationsJeremy Allred, Kharmen Bharucha, Can Özütemiz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia ControlBartosz Grzywacz, Laura Moench, David McKenna, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Stem Cells and Development|May 14, 2019
Pioneering Adoptive Immunotherapy with Natural Killer CellsBartosz Grzywacz
Human Immunology|July 18, 2002
NK cells become Ki-67+ in MLC and expand depending on the lack of ligand for KIR on stimulator cells in IL-2 supplemented MLCBartosz Grzywacz, Dorota Dlubek, Andrzej Lange
Frontiers in Immunology|September 27, 2019
Human NK Cell Development: One Road or Many?Frank Cichocki, Bartosz Grzywacz, Jeffrey S Miller
Best Practice & Research. Clinical Haematology|September 16, 2008
Use of natural killer cells as immunotherapy for leukaemiaBartosz Grzywacz, Jeffrey S Miller, Michael R Verneris
Cytometry. Part B, Clinical Cytometry|November 18, 2021
Patients without cutaneous T-cell lymphoma frequently harbor CD4 T-lymphocytes that lack CD26 and/or CD7Bartosz Grzywacz, Sophia Yohe, Paula Shivers, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 30, 2021
Hemophagocytic lymphohistiocytosis induced by Toxoplasma gondii infection diagnosed by a bone marrow biopsy and DNA next-generation sequencing in an allogeneic hematopoietic stem cell transplant recipientKaram M Obeid, Bartosz Grzywacz, Patricia Ferrieri, et al.
Blood|December 22, 2010
Natural killer-cell differentiation by myeloid progenitorsBartosz Grzywacz, Nandini Kataria, Niketa Kataria, et al.
American Journal of Clinical Pathology|July 16, 2019
CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-upScott R Gilles, Sophia L Yohe, Michael A Linden, et al.
Bone Marrow Transplantation|August 9, 2020
Chimeric antigen receptor T-cell therapy for HIV-associated diffuse large B-cell lymphoma: case report and management recommendationsJeremy Allred, Kharmen Bharucha, Can Özütemiz, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 30, 2018
Natural Killer Cell Homing and Persistence in the Bone Marrow After Adoptive Immunotherapy Correlates With Better Leukemia ControlBartosz Grzywacz, Laura Moench, David McKenna, et al.
Pageof 3